글로벌 바이러스성 위장염 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 바이러스성 위장염 시장

바이러스성 위장염 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간에 3.99%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

위장관의 내부 점막은 바이러스성 위장염으로 인해 염증이 생기고 부어 오르며 자극을 받습니다. 이 질병은 바이러스 로 인해 발생합니다. 위, 소장, 대장이 모두 감염될 수 있습니다. 바이러스성 위장염은 매우 흔합니다. 보통 며칠 동안만 지속되며 치료가 필요하지 않습니다. 가장 심각한 위험은 구토와 설사로 인한 체액 손실로 인한 탈수입니다. 위장 독감이라고도 합니다. 이 질환은 복통, 현기증, 설사, 메스꺼움, 구토, 두통, 오한, 식욕 부진, 발열, 관절 경직, 발한, 근육통, 체중 감소 등이 특징입니다.

위장관 질환의 유병률 증가와 의료비 지출 증가는 시장 성장률에 영향을 미치는 주요 요인입니다. 또한, 노령 인구 증가, 신제품 출시, 공공 및 민간 기관에서 질병과 예방 옵션에 대한 인식을 확산하기 위한 이니셔티브 증가는 바이러스성 위장염 시장을 확대할 요인입니다. 마찬가지로 도시화 증가와 건강에 대한 인식 증가와 같은 다른 요인도 시장 성장률에 긍정적인 영향을 미칠 것입니다.

2021~2028년 예측 기간 동안 연구 개발 활동의 증가, 파이프라인 제품 수의 증가, 희귀 질환에 대한 임상 시험은 바이러스성 위장염 시장에 유익한 기회를 제공할 것입니다.

However, high cost of the treatment, complications associated with the disease such as severe dehydration and high initial investment needed in research and development activities for the enhancement of vaccines, drugs and kits utilized in the treatment are the factors that will hinder the market growth. Lack of awareness and strict regulations imposed on the treatment and usage of chemicals in drug manufacturing procedure will further challenge the viral gastroenteritis market in the forecast period mentioned above.

This viral gastroenteritis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the viral gastroenteritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Viral Gastroenteritis Market Scope and Market Size

The viral gastroenteritis market is segmented on the basis of type, treatment, diagnosis, indication, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the viral gastroenteritis market is segmented into norovirus and rotavirus.
• On the basis of treatment, the viral gastroenteritis market is segmented into intravenous fluids, antimotility agents, electrolytes, antiemetic drugs, antidiarrheal drugs and others. 
• On the basis of diagnosis, the viral gastroenteritis market is segmented into physical examination, rapid stool test and others.
• On the basis of indication, the viral gastroenteritis market is segmented into abdominal pain, dizziness, diarrhea, nausea, vomiting, headache, chills, loss of appetite, fever, joint stiffness, sweating, muscle pain, weight loss and others.
• On the basis of dosage, the viral gastroenteritis market is segmented into tablet, injection and others.
• On the basis of route of administration, the viral gastroenteritis market is segmented into oral, intravenous and others.
• On the basis of end-users, the viral gastroenteritis market is segmented into clinic, hospital and others.

The viral gastroenteritis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Viral Gastroenteritis Market Country Level Analysis

Viral gastroenteritis market is analyzed and market size information is provided by the country, type, treatment, diagnosis, indication, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the viral gastroenteritis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the viral gastroenteritis market due to the rising awareness about diseases, health related problems arising due to presence of major key players, rise in the prevalence of viral gastroenteritis and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising demand for rapid diagnostic tests gastrointestinal diseases and growing awareness about available treatment option for viral gastroenteritis.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Viral gastroenteritis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Viral Gastroenteritis Market Share Analysis

바이러스성 위장염 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 바이러스성 위장염 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

바이러스성 위장염 시장 보고서에 포함된 주요 기업은 Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Johnson & Johnson Private Limited, Allergan, Bayer AG, Baxter, AstraZeneca, Bausch Health Companies Inc., Takeda Pharmaceutical Company Limited., Mylan NV, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Fresenius Kabi AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Merck Sharp & Dohme Corp., Eli Lilly and Company, Bristol-Myers Squibb Company, Cipla Inc., Astellas Pharma Inc., Abbott, Dr. Reddy's Laboratories Ltd. 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-67095